PortfoliosLab logo
AdaptHealth Corp. (AHCO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US00653Q1022

CUSIP

00653Q102

IPO Date

May 24, 2018

Highlights

Market Cap

$1.19B

EPS (TTM)

$0.61

PE Ratio

14.39

Total Revenue (TTM)

$2.47B

Gross Profit (TTM)

$552.89M

EBITDA (TTM)

$426.09M

Year Range

$7.11 - $11.90

Target Price

$13.00

Short %

8.21%

Short Ratio

4.74

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AdaptHealth Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%December2025FebruaryMarchAprilMay
-15.10%
109.35%
AHCO (AdaptHealth Corp.)
Benchmark (^GSPC)

Returns By Period

AdaptHealth Corp. (AHCO) returned -13.50% year-to-date (YTD) and -15.63% over the past 12 months.


AHCO

YTD

-13.50%

1M

-13.86%

6M

-19.11%

1Y

-15.63%

5Y*

-12.92%

10Y*

N/A

^GSPC (Benchmark)

YTD

-4.26%

1M

11.24%

6M

-5.02%

1Y

8.55%

5Y*

14.02%

10Y*

10.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of AHCO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202513.66%5.18%-4.75%-21.49%-3.23%-13.50%
2024-0.96%41.69%12.51%-14.42%-3.76%5.49%13.60%-3.26%2.18%-8.37%-2.53%-5.08%30.59%
202311.50%-25.38%-22.26%-4.42%-11.78%16.13%12.90%-13.17%-23.72%-19.45%15.69%-14.03%-62.07%
2022-22.73%-7.78%-8.03%-21.02%42.10%0.28%22.56%-18.72%4.51%21.41%-2.15%-13.85%-21.42%
20211.89%-19.60%19.47%-20.95%-9.88%4.66%-18.31%7.37%-3.12%17.00%-27.96%24.61%-34.88%
202020.86%21.70%-0.93%-1.50%2.66%-0.49%20.99%8.98%2.73%25.17%9.38%25.79%242.08%
20190.81%0.50%0.30%0.70%0.30%0.40%0.79%-0.39%0.10%0.10%-11.19%21.33%11.70%
20180.00%-0.82%0.83%0.41%-0.21%0.62%0.20%0.31%1.34%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AHCO is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AHCO is 3030
Overall Rank
The Sharpe Ratio Rank of AHCO is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of AHCO is 3434
Sortino Ratio Rank
The Omega Ratio Rank of AHCO is 3434
Omega Ratio Rank
The Calmar Ratio Rank of AHCO is 3737
Calmar Ratio Rank
The Martin Ratio Rank of AHCO is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AdaptHealth Corp. (AHCO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The current AdaptHealth Corp. Sharpe ratio is -0.33. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AdaptHealth Corp. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
-0.27
0.44
AHCO (AdaptHealth Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


AdaptHealth Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-79.49%
-8.35%
AHCO (AdaptHealth Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AdaptHealth Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AdaptHealth Corp. was 83.84%, occurring on Dec 20, 2023. The portfolio has not yet recovered.

The current AdaptHealth Corp. drawdown is 79.49%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.84%Feb 2, 2021727Dec 20, 2023
-38.02%Mar 6, 20209Mar 18, 202011Apr 2, 202020
-27.08%Jun 23, 20206Jun 30, 202025Aug 5, 202031
-23.57%Aug 13, 202030Sep 24, 202010Oct 8, 202040
-21.34%Jul 9, 201996Nov 20, 201915Dec 12, 2019111

Volatility

Volatility Chart

The current AdaptHealth Corp. volatility is 20.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%December2025FebruaryMarchAprilMay
20.60%
11.43%
AHCO (AdaptHealth Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AdaptHealth Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of AdaptHealth Corp., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 49.3% positive surprise.


-2.00-1.50-1.00-0.500.000.5020212022202320242025
-0.05
0.28
Actual
Estimate

Valuation

The Valuation section provides an overview of how AdaptHealth Corp. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for AHCO, comparing it with other companies in the Medical Devices industry. Currently, AHCO has a P/E ratio of 14.4. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AHCO relative to other companies in the Medical Devices industry. Currently, AHCO has a P/S ratio of 0.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AHCO in comparison with other companies in the Medical Devices industry. Currently, AHCO has a P/B value of 0.8. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items